🔗 Visit the ClinicalTrials.gov page for NCT00112723
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Molecular targeted approaches in mantle cell lymphoma. | Semin Hematol | 2011 | 0.88 |
| 2 | A test of highly optimized tolerance reveals fragile cell-cycle mechanisms are molecular targets in clinical cancer trials. | PLoS One | 2008 | 0.85 |
| 3 | A phase I trial of flavopiridol in relapsed multiple myeloma. | Cancer Chemother Pharmacol | 2013 | 0.84 |
| 4 | Potential of protein kinase inhibitors for treating herpesvirus-associated disease. | Trends Microbiol | 2013 | 0.76 |
| 5 | Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells. | PeerJ | 2016 | 0.75 |